TRESIBA Penf 100 U/ml 5 cartouche 3 ml

7680625620017 CH-62562 A10AE06 07.06.1.
TRESIBA Penf 100 U/ml 5 cartouche 3 ml
TRESIBA Penf 100 U/ml 5 cartouche 3 ml
1 / 2
google

Details

Product number
6256201
CPT
-
Packaging group
5 x 3
Unit
ml
Composition
insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., glycerolum, zincum ut zinci acetas dihydricus, phenolum, metacresolum 1.72 mg, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Tresiba Penfill, Injektionslösung
Injektionslösung
5 x 3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/05/2025
Patient information leaflet
Français
13/05/2025
Patient information leaflet
Italien
13/05/2025
Professional SmPC
Allemand
13/05/2025
Professional SmPC
Français
13/05/2025
Professional SmPC
Italien
13/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
600.0 NMOL Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.72 MG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 105.15
Specialties list
Yes
Generic
No
SL addition date: 01/06/2013

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
62562
Drug name
Tresiba Penfill, Injektionslösung
Galenic form
LSILP
ATC Code
A10AE06
Authorization status
Z
Dispensation category
B
First authorization
12/03/2013
Authorization expiration date
31/12/9999
IT number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Packaging details

Description (FR)
TRESIBA Penf 100 U/ml 5 cartouche 3 ml
Description (DE)
TRESIBA Penfill 100 E/ml 5 Patrone 3 ml
Market launch
12/03/2013
Narcotic (BTM)
No